Metformin the World's First Anti-Ageing Life Extension Wonder Drug?

Personal_Finance / Life Extension Jul 09, 2019 - 07:29 AM GMT

We are currently galloping full speed along an exponential curve that unlike the neural nets of the 1990's, that promised a lot but delivered very little, this time it really looks like we are on the verge of AI success, not only that but it heralds changes in every aspect of our lives most of which we cannot even imagine today, hence the term the singularity is often used, the AI event horizon beyond which we cannot see.

My latest analysis in this series focuses on how to profit and capitalise on the unfolding machine intelligence driven mega-trend through investing in leveraged to AI Human Life Extension stocks.

Intro & Humanities Quest for Immortality
Extending Telomeres
Slowing Down the Ageing Process - Strength Training
Slowing Down the Ageing Process - Metformin
LIMITLESS - Improving Cognitive Function and Fighting Brain Ageing Right Now!
Investing in Life Extending Pharma Stocks
Stock 1 - Primary
Stock 2 - Tertiary
Stock 3 - Tertiary
Stock 4 - ETF
AI Stocks Investing Portfolio Update

The whole of this analysis including 4 sector stocks to invest in has first been made available to Patrons who support my work: Investing to Profit and Benefit from Human Life Extension AI Stocks and Technologies

So for immediate First Access to ALL of my analysis and trend forecasts then do consider becoming a Patron by supporting my work for just $3 per month. https://www.patreon.com/Nadeem_Walayat.

Metformin

Whilst we await a working medical solution to telomere shortening, what else is out there? Well the internet for want of a better word is littered with scams potions that at best don't work and at worse do more harm then good!. The thing about ageing is that our bodies work less efficiently over time and thus develop deficiencies.

Therefore logic would dictate that you want to aim to bridge that gap between reduction of enzymes and hormones with some supplementation, limited and occasional supplementation but definitely don't seek to become a hypochondriac pill guzzler. Nevertheless there are some drugs that studies show favourable results for , albeit with side effects as the price paid for taking ANY drug. Most notable of which is the diabetes treatment drug Metformin that has several studies to back up its anti ageing claims, and that the generic versions are relatively cheap and easily bought online!

Metformin is a FDA approved drug in use in the US since the early 1990s for prevention and treatment of type 2 diabetes. Studies have shown it to be effective in extending life spans of mice. Analysis of human diabetic populations taking Metformin back up its anti-ageing properties in fighting age related diseases such as cardiovascular disease, reducing risk of cancer, the mechanisms of actions are due to its effects in reducing insulin levels and improved insulin action and currently over 100 human clinical trials are in progress to test its anti-ageing properties.

It appears that as increasing lean muscle mass does, so Metformin does have the effect of changing the biology of ageing tissues to a younger profile.

The rest of this this analysis including 4 sector stocks to invest in to profit from AI driven Life Extension has first been made available to Patrons who support my work: Investing to Profit and Benefit from Human Life Extension AI Stocks and Technologies

So for immediate First Access to ALL of my analysis and trend forecasts then do consider becoming a Patron by supporting my work for just $3 per month. https://www.patreon.com/Nadeem_Walayat.

Scheduled Analysis :

Stock Market Trend Forecast Update
Gold and Silver Trend Analysis Update
China Stock Market SSEC
Bitcoin Update
UK Housing market series
Machine Intelligence Investing stocks sub sector analysis

Recent Analysis includes:

And ensure you are subscribed to my FREE Newsletter to get my public analysis in your email in box (only requirement is an email address).

Your analyst

Nadeem Walayat

http://www.marketoracle.co.uk

Nadeem Walayat has over 30 years experience of trading derivatives, portfolio management and analysing the financial markets, including one of few who both anticipated and Beat the 1987 Crash. Nadeem's forward looking analysis focuses on UK inflation, economy, interest rates and housing market. He is the author of five ebook's in the The Inflation Mega-Trend and Stocks Stealth Bull Market series that can be downloaded for Free.

Nadeem is the Editor of The Market Oracle, a FREE Daily Financial Markets Analysis & Forecasting online publication that presents in-depth analysis from over 1000 experienced analysts on a range of views of the probable direction of the financial markets, thus enabling our readers to arrive at an informed opinion on future market direction. http://www.marketoracle.co.uk

Disclaimer: The above is a matter of opinion provided for general information purposes only and is not intended as investment advice. Information and analysis above are derived from sources and utilising methods believed to be reliable, but we cannot accept responsibility for any trading losses you may incur as a result of this analysis. Individuals should consult with their personal financial advisors before engaging in any trading activities.

Nadeem Walayat Archive

Only logged in users are allowed to post comments. Register/ Log in

The Market Oracle is a FREE Financial Markets Forecasting & Analysis web-site.
(c) 2005-2022 MarketOracle.co.uk (Market Oracle Ltd) - Market Oracle Ltd asserts copyright on all articles authored by our editorial team and all comments posted. Any and all information provided within the web-site, is for general information purposes only and Market Oracle Ltd do not warrant the accuracy, timeliness or suitability of any information provided on this site. nor is or shall be deemed to constitute, financial or any other advice or recommendation by us. and are also not meant to be investment advice or solicitation or recommendation to establish market positions. We do not give investment advice and our comments are an expression of opinion only and should not be construed in any manner whatsoever as recommendations to enter into a market position either stock, option, futures contract, bonds, commodity or any other financial instrument at any time. We recommend that independent professional advice is obtained before you make any investment or trading decisions. By using this site you agree to this sites Terms of Use. From time to time we promote or endorse certain products / services that we believe are worthy of your time and attention. In return for that endorsement and only in the cases where you purchase directly though us may we be compensated by the producers of those products.